Metabolic Syndrome Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer
PURPOSE: This research investigated the predictive role of metabolic syndrome (MetS) in breast cancer neoadjuvant chemotherapy (BCNACT) response. METHODS: One hundred fifty primary breast cancer (BC) patients who underwent neoadjuvant chemotherapy (NACT) were included retrospectively. MetS, MetS com...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284232/ https://www.ncbi.nlm.nih.gov/pubmed/35847887 http://dx.doi.org/10.3389/fonc.2022.899335 |